Major bleeding risk associated with warfarin and co‐medications in the elderly population
- 17 August 2011
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 20 (10) , 1057-1063
Abstract
Purpose: Warfarin management in the elderly population is complex as medicines prescribed for concomitant diseases may further increase the risk of major bleeding associated with warfarin use. We aimed to quantify the excess risk of bleeding‐related hospitalisation when warfarin was co‐dispensed with potentially interacting medicines.Methods: A retrospective cohort study was undertaken over a 4‐year period from July 2002 to June 2006 to examine bleeding risk associated with medications co‐administered in patients taking warfarin using an administrative claims database from the Australian Department of Veterans' Affairs. All veterans aged 65 years and over who were new users of warfarin were followed until death or study end. Risk of bleeding was assessed using a Poisson GEE model adjusting for age, gender, socioeconomic status, co‐morbidity index, previous bleeding related hospitalisations and indicators of health service use.Results: Overall, 17661 veterans who used warfarin at any time during the study period were included. The overall incidence rate of bleeding‐related hospitalisations was 4.1 (95% CI 3.7–4.6) per 100 person‐years in veterans who were not receiving potentially interacting medicines. Bleeding‐related hospitalisation rates were significantly increased when warfarin was co‐prescribed with low‐dose aspirin (Adjusted rate ratio (AdjRR) 1.44, 95% CI 1.00–2.07), clopidogrel (AdjRR 2.23, 95% CI 1.48–3.36), clopidogrel with aspirin (AdjRR 3.44, 95% CI 1.28–9.23), amiodarone (AdjRR 3.33, 95% CI 1.38–8.00) and antibiotics (AdjRR 2.34, 95% CI 1.55–3.54).Conclusions: Models assessing bleeding risk with warfarin should take account of the range of potentially harmful medicine combinations used in elderly people with comorbid conditions. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Health and Medical Research Council/Australian Research Council Ageing Well Ageing Productively (APP ID 401832)
This publication has 39 references indexed in Scilit:
- Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular DiseaseStroke, 2008
- Effect of oral antiplatelet agents on major bleeding in users of coumarinsThrombosis and Haemostasis, 2008
- Drug interactions with warfarin: what clinicians need to knowCanadian Medical Association Journal, 2007
- Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleedingCanadian Medical Association Journal, 2007
- The risk of bleeding with warfarin: A systematic review and performance analysis of clinical prediction rulesThrombosis and Haemostasis, 2007
- Repeat adverse drug reactions causing hospitalization in older Australians: a population‐based longitudinal study 1980–2003British Journal of Clinical Pharmacology, 2006
- Adapting the Rx-Risk-V for Mortality Prediction in Outpatient PopulationsMedical Care, 2006
- Cerebral haemorrhage induced by warfarin—the influence of drug–drug interactionsPharmacoepidemiology and Drug Safety, 2006
- Which drugs cause preventable admissions to hospital? A systematic reviewBritish Journal of Clinical Pharmacology, 2006
- Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)American Heart Journal, 2006